Campbell's: Deleveraging soup-to-snacks portfolio priced for permanent decline, not FY28-29 margin recovery

Stevie AI on Campbell's Company (CPB-USA | campbellscom)

9/20/2026

Summary

Campbell's is a two-segment packaged food company anchored by the #1 condensed soup franchise in North America (Campbell's, Rao's, Pacific) and a Snacks business built around Goldfish and Pepperidge Farm. The structural insight is that the market is pricing CPB as a melting ice cube in structurally declining soup and cracker categories, when in fact Rao's-led premiumization in Meals & Beverages is offsetting mainstream softness while a disciplined $100M SG&A takeout and deleveraging program is set to rebuild EPS from a FY26 trough of ~$2.15-2.20 back above $3.00 by FY28-29. The stock's 9-10x forward earnings multiple embeds almost no credit for this margin recovery path, but the near-term setup is genuinely mixed: Snacks stabilization is lagging, FY27 faces 5-6% input inflation, and management itself has guided EPS to the low end of prior ranges. FY2024 revenue of $9.6B grew to $10.3B in FY2025 (aided by the Rao's/La Regina acquisition), with net income flat around $0.6B and EPS rising modestly from $1.89 to $2.01. Gross margin of 30.4% and operating margin of 13.2% in FY2025 reflect a business generating durable but unglamorous profitability, with FCF conversion supporting a still-elevated net debt load of roughly $7.2-7.4B across the forecast horizon. Management's own FY26 guidance of EPS at $2.20 and below, alongside Snacks commentary that is 'fairly similar to Q3, might be a little worse,' signals a company managing through a soft patch rather than accelerating. Applying a 10x forward P/E — modestly below the packaged food peer average of 12-14x to reflect CPB's structurally declining core categories, elevated leverage, and capital allocation constrained to deleveraging over buybacks — to the FY2026-2029 EPS path of $2.15/$2.33/$2.99/$3.47 yields price targets of $21.50 in FY26, $23.30 in FY27, $29.90 in FY28, and $34.70 in FY29. The nearer-term targets imply limited upside from the current $20.69 price, while the FY28-29 targets suggest meaningful re-rating potential if the SG&A takeout and Rao's-led mix shift deliver as management projects — but that payoff is 2-3 years out and contingent on execution the market has reason to discount given recent guidance cuts.

Thesis

1. **Rao's and premium M&B is the one genuine growth engine, but it's not big enough yet to offset Snacks and mainstream soup decline.** Rao's, Pacific, and protein soup extensions have driven real premiumization within Meals & Beverages, and the segment is expected to show 'solid growth' in Q4 FY26 partly aided by a $30M favorable ERP lap. However, this premium tier remains a minority of segment revenue, and the read-through from management's own strategic scoring — 4.5/10 on value innovation, 4.0/10 on market expansion — is that this is incremental adjacent extension, not category reinvention. Investors should not extrapolate Rao's growth rates onto the broader $10B+ revenue base. 2. **The $100M SG&A takeout is the primary lever for FY27-29 EPS recovery, and it is a real, quantifiable program rather than vague cost talk.** Management has been explicit: two-year target, front-loaded into FY27 where possible, paired with an early retirement program that has been 'well-received' and additional plant network efficiency work. Against 5-6% input inflation and a ~$40M incentive comp reset in FY27, this program is the difference between EPS stagnating near $2.20 and the modeled path to $2.99 by FY28 and $3.47 by FY29. The credibility of this program, more than any top-line acceleration, is the crux of the bull case. 3. **Deleveraging discipline protects the investment-grade rating and creates optionality, even though it caps near-term shareholder returns.** With net debt sitting at $7.2-7.4B and leverage targeted toward low-3x net debt/EBITDA, management has explicitly subordinated buybacks to balance sheet repair, and is even exploring hybrid debt with ~50% equity credit from rating agencies to manage the glide path. This is conservative but appropriate given the flat dividend policy and mature end markets — it reduces tail risk of a ratings downgrade that would raise the cost of capital in a business already generating modest FCF ($0.7-0.9B annually). 4. **The market is pricing near-term guidance cuts as a permanent de-rating rather than a cyclical inflation trough.** CPB shares reflect skepticism after management moved EPS guidance down to '$2.20 and below' and flagged Snacks as 'a little worse' than prior quarters. But the forecast embeds a clear mechanical path: FY27 absorbs peak inflation (5-6%, oil-driven) and comp reset costs, while FY28-29 show margin recovery as SG&A savings compound and pricing/mix normalize. A 10x forward multiple on trough-adjacent FY26/27 EPS is not unreasonable, but that same multiple applied to FY28-29 recovery EPS implies significant undervaluation if execution holds. 5. **Capital allocation is intentionally boring — and that is the correct strategy for a business with limited pricing power.** Management describes pricing as a 'last resort,' relying instead on trade ROI optimization and cost takeout to protect margin in categories where private label competes aggressively. CapEx is held to 'highest priority projects only' and M&A is explicitly 'off the table,' meaning the equity story is entirely about internal margin repair and debt paydown rather than portfolio reshaping or growth investment — a lower-risk, lower-optionality profile that justifies a below-peer-average multiple. 6. **Catalysts are binary and near-dated: the FY26 Q4 print and early FY27 guidance will either validate or undermine the recovery thesis.** The August 2026 Q4 report will show whether the $2.20-and-below EPS floor holds, how Snacks stabilization trends into FY27, and whether the La Regina/Rao's acquisition accounting and tariff refund ($0.03-0.04/share) provide any offsetting lift. FY27 guidance, delivered alongside real-time visibility into oil-driven inflation assumptions, will be the key test of whether the SG&A program is tracking to plan — a positive read would justify moving toward the higher end of the price target range; a miss would validate continued multiple compression.

Risks

1. **Persistent input cost inflation with structurally limited pricing power.** Management's own 5-6% FY27 inflation estimate (base ~3% plus 2-3% incremental from elevated oil/geopolitical risk) arrives in a category where private label penetration is already high and consumer elasticity is well-documented; management explicitly treats pricing as a 'last resort,' meaning margin protection depends almost entirely on cost-side execution (SG&A takeout, working capital) rather than revenue-side flexibility. If oil stays above $100/barrel through FY27, inflation could exceed the modeled range and compress margins further than currently forecast. 2. **Snacks segment stabilization is lagging and could deteriorate further.** Management's own characterization — 'fairly similar to Q3, might be a little worse' — is a soft, unquantified signal that the second-largest segment has no clear inflection catalyst. Goldfish and Pepperidge Farm face salty/sweet snack category headwinds and private-label competition; continued softness here would undermine the blended EPS recovery path even if M&B/Rao's performs as expected. 3. **Execution risk on the $100M SG&A takeout program.** The entire FY27-29 EPS recovery thesis rests on realizing this cost program on schedule, including an early retirement initiative and plant network efficiency work. Restructuring programs of this type frequently slip in timing or fall short of targeted run-rate savings, and any shortfall would directly compress the FY28-29 EPS estimates ($2.99/$3.47) that justify the higher price targets. 4. **Elevated leverage constrains flexibility and could face rating pressure.** Net debt of $7.2-7.4B against modest FCF generation ($0.7-0.9B annually) leaves limited room for error; management's consideration of hybrid debt issuance (accepting a higher coupon for partial equity credit) signals the balance sheet is being actively managed under constraint. Any EBITDA shortfall from inflation or Snacks weakness would delay the low-3x leverage target and increase downgrade risk, which would raise funding costs and further limit capital allocation optionality. 5. **Structural category decline in condensed and mainstream ready-to-serve soup.** The core soup category — where Campbell's holds the #1 position — is described as being in long-term structural decline, with private label intensifying share pressure. Rao's and premium extensions are growing but represent a minority of the base; if premium growth decelerates or fails to fully offset mainstream erosion, blended M&B growth could disappoint even as management touts segment-level 'solid growth' language. 6. **Flat dividend and no buyback optionality limit total shareholder return in a scenario where the EPS recovery is delayed.** With deleveraging explicitly prioritized over capital returns and no near-term dividend increase intended, the equity offers limited downside protection via yield growth or buyback support if the FY27-29 EPS recovery path proves slower than modeled — meaning much of the total return depends on the multiple re-rating thesis playing out, which is not assured given the company's contested competitive positioning (scored 4.5/10 on value innovation, 4.0/10 on market expansion).

📈 Price Targets